GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » Debt-to-Equity

Eurofins-Cerep (XPAR:ALECR) Debt-to-Equity : 0.01 (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep Debt-to-Equity?

Eurofins-Cerep's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.00 Mil. Eurofins-Cerep's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.32 Mil. Eurofins-Cerep's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €67.43 Mil. Eurofins-Cerep's debt to equity for the quarter that ended in Jun. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Eurofins-Cerep's Debt-to-Equity or its related term are showing as below:

XPAR:ALECR' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.01   Max: 0.01
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Eurofins-Cerep was 0.01. The lowest was 0.00. And the median was 0.01.

XPAR:ALECR's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.275 vs XPAR:ALECR: 0.01

Eurofins-Cerep Debt-to-Equity Historical Data

The historical data trend for Eurofins-Cerep's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins-Cerep Debt-to-Equity Chart

Eurofins-Cerep Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eurofins-Cerep Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Competitive Comparison of Eurofins-Cerep's Debt-to-Equity

For the Diagnostics & Research subindustry, Eurofins-Cerep's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins-Cerep's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins-Cerep's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Eurofins-Cerep's Debt-to-Equity falls into.



Eurofins-Cerep Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Eurofins-Cerep's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Eurofins-Cerep's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins-Cerep  (XPAR:ALECR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Eurofins-Cerep Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins-Cerep Business Description

Traded in Other Exchanges
N/A
Address
Le bois l Eveque, Celle l Evescault, FRA, 86600
Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.

Eurofins-Cerep Headlines

No Headlines